A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer

NCT04492488 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Advanced or Metastatic Gastric Cancer
Advanced or Metastatic Gastroesophageal Junction Cancer

Interventions

DRUG: MRG002

Sponsor

Shanghai Miracogen Inc.